The efficacy and safety of neoadjuvant nimotuzumab for gastric cancer: A meta-analysis of randomized controlled studies

CONCLUSIONS: Neoadjuvant nimotuzumab might provide no additional benefits to the treatment of gastric cancer.PMID:34918627 | DOI:10.1097/MD.0000000000027709

Source: Cancer Control - December 17, 2021 Category: Cancer & Oncology Authors: Qian Wang Xiao-Li Fu Guo-Dong Wei Long Zhao Pei-Jun Zhang Dairong Li Hui-Qing Zhang Source Type: research